Lowell Thomas Holden is CFO of Nascent Biotech Inc.. Currently has a direct ownership of 10 Million shares of NBIO, which is worth approximately $0. The most recent transaction as insider was on Jun 30, 2024, when has been sold 96,000 shares (Common Stock) at a price of $0.09 per share, resulting in proceeds of $8,640. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10M
0% 3M change
0% 12M change
Total Value Held $0

LOWELL THOMAS HOLDEN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 30 2024
BUY
Other acquisition or disposition
$8,640 $0.09 p/Share
96,000 Added 0.95%
10,005,477 Common Stock
Mar 31 2024
BUY
Other acquisition or disposition
$20,250 $0.18 p/Share
112,500 Added 1.12%
9,909,477 Common Stock
Dec 29 2023
BUY
Other acquisition or disposition
$20,340 $0.17 p/Share
119,650 Added 1.21%
9,796,977 Common Stock
Sep 29 2023
BUY
Other acquisition or disposition
$166,356 $0.12 p/Share
1,386,300 Added 12.53%
9,677,327 Common Stock
Jun 29 2023
SELL
Bona fide gift
$35,000 $0.05 p/Share
700,000 Reduced 7.79%
8,291,027 Common Stock
Jun 07 2023
BUY
Open market or private purchase
$5,200 $0.04 p/Share
130,000 Added 1.52%
8,409,277 Common Stock
Mar 31 2023
BUY
Other acquisition or disposition
$34,860 $0.06 p/Share
581,000 Added 6.56%
8,279,277 Common Stock
Feb 09 2023
SELL
Bona fide gift
$84,000 $0.12 p/Share
700,000 Reduced 8.24%
7,798,277 Common Stock
Jan 27 2023
BUY
Open market or private purchase
$2,800 $0.14 p/Share
20,000 Added 0.24%
8,418,277 Common Stock
Jan 27 2023
BUY
Open market or private purchase
$2,800 $0.14 p/Share
20,000 Added 0.24%
8,418,277 Common Stock
Dec 30 2022
BUY
Grant, award, or other acquisition
$46,200 $0.2 p/Share
231,000 Added 2.68%
8,398,277 Common Stock
Jul 21 2022
SELL
Open market or private sale
$1,300 $0.26 p/Share
5,000 Reduced 0.06%
8,112,277 Common Stock
Apr 14 2022
SELL
Bona fide gift
$56,000 $0.08 p/Share
700,000 Reduced 7.79%
8,283,077 Common Stock
Mar 31 2022
BUY
Other acquisition or disposition
$12,900 $0.06 p/Share
215,000 Added 2.34%
8,983,077 Common Stock
Mar 09 2022
BUY
Other acquisition or disposition
$55,000 $0.05 p/Share
1,100,000 Added 11.15%
8,768,077 Common Stock
Jan 07 2022
SELL
Bona fide gift
$85,000 $0.05 p/Share
1,700,000 Reduced 19.23%
7,141,777 Common Stock
Jun 30 2021
BUY
Other acquisition or disposition
$17,370 $0.1 p/Share
173,700 Added 1.93%
8,841,777 Common Stock
Jun 30 2021
BUY
Other acquisition or disposition
$10,422 $0.06 p/Share
173,700 Added 1.93%
8,841,777 Common Stock
Apr 15 2021
SELL
Bona fide gift
$85,000 $0.05 p/Share
1,700,000 Reduced 16.4%
8,668,077 Common Stock
Mar 31 2021
BUY
Other acquisition or disposition
$48,600 $0.06 p/Share
810,000 Added 7.25%
10,368,077 Common Stock
Mar 26 2021
BUY
Other acquisition or disposition
$60,000 $0.06 p/Share
1,000,000 Added 9.47%
9,558,077 Common Stock
Dec 31 2020
BUY
Other acquisition or disposition
$72,100 $0.05 p/Share
1,442,000 Added 14.42%
8,558,077 Common Stock
Sep 30 2020
BUY
Other acquisition or disposition
$8,958 $0.07 p/Share
127,970 Added 1.77%
7,116,077 Common Stock

Also insider at

SKKY
Skkynet Cloud Systems, Inc. Technology
LTH

Lowell Thomas Holden

CFO
Vero Beach, FL

Track Institutional and Insider Activities on NBIO

Follow Nascent Biotech Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBIO shares.

Notify only if

Insider Trading

Get notified when an Nascent Biotech Inc. insider buys or sells NBIO shares.

Notify only if

News

Receive news related to Nascent Biotech Inc.

Track Activities on NBIO